Back to the Top 100
OpenEvidence logo

Rank 75AI & Clinical Intelligence

OpenEvidence

Generates AI-powered, evidence-based answers to clinical questions, utilizing medical literature to support healthcare decisions.

Visit website
Signal Score
84.1
Total raised
$15M
Stage
Series A
Founded
2021
Headquarters
San Francisco, United States
Region
North America

Their signal

Backed by rigorous evaluation, OpenEvidence provides highly trusted, citation-backed clinical intelligence, serving as an essential reference for medical providers globally.

Signal Score 84.1editorial estimate, see how it is built
Capital (25% weight)75

Total raised, quality of investors and recency of the last round.

Growth (25% weight)85

Revenue trajectory, customer count, hiring and market pull.

Clinical & regulatory (20% weight)89

Peer-reviewed evidence, FDA/CE clearances and live health-system deployments.

Team (15% weight)93

Founder track record, clinical depth on the bench and technical leadership.

Online visibility (15% weight)82

Search presence, press coverage, founder and brand reach, and how often the company shows up where buyers look.

Also in AI & Clinical Intelligence

Figures are subjective research desk estimates compiled from public sources and refreshed daily, published as editorial commentary. Company marks are shown for identification only and imply no endorsement or affiliation. Want a correction, an update or removal? and see our corrections and removals policy.